PAREXEL International appointed Maykin Ho to its Board of Directors

– USA, MA – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors have elected Maykin Ho, Ph.D., to the Board, effective August 26, 2015.

Dr. Ho is a retired partner of the Goldman Sachs Group where she served as advisory director of Global Healthcare Investment Banking, as senior biotechnology analyst, and as co-head of healthcare for Global Investment Research. Earlier in her career, Dr. Ho held various managerial positions in licensing, strategic planning, marketing and research at DuPont-Merck Pharmaceuticals and DuPont de Nemours & Company.

“With more than 30 years of experience in the healthcare and finance industries, Dr. Ho is an excellent addition to our Company, and we welcome her to our Board of Directors,” said Josef von Rickenbach, Chairman and Chief Executive Officer, PAREXEL. “As we continue to be a premier provider to the biopharmaceutical industry in the development and commercialization of new and innovative drug treatments worldwide, our clients and shareholders will benefit from Maykin’s expertise, insight and perspective.”

Dr. Ho is a member of the Board of Directors of the Aaron Diamond AIDS Research Center and of Agios Pharmaceuticals. She formerly served on the Investment Committee of the Society of Neuroscience, as well as the Advisory Council for the Department of Biological Chemistry and Molecular Pharmacology of the Harvard Medical School.

“PAREXEL is a leader in biopharmaceutical drug development, and I am honored to join the Board of Directors,” said Dr. Ho. “I look forward to working with the Board of Directors and the management team to help achieve the Company’s operational and financial goals and advance PAREXEL’s mission to make the world a healthier place.”

After receiving her Ph.D. in microbiology and immunology and a B.S. in biology from the State University of New York, Downstate Medical Center, Dr. Ho was a postdoctoral fellow at Harvard Medical School. She is also a graduate of the Advanced Management Program at Duke University’s Fuqua School of Business.

Dr. Ho’s accomplishments have been recognized in the industry. Among her awards and honors, she received the 2007 Asian Women in Business Corporate Leadership Award and the 2004 National Association for Asian American Professionals Leadership Award.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of expertise-based contract research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL has offices in 80 locations in 51 countries around the world, and had approximately 18,660 employees in the fourth quarter.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.

here the original post =>